Significance of lung hyperinflation in chronic obstructive pulmonary disease

Journal of Organ Dysfunction

Volumn 3, Issue 1, 2007, Pages 44-54

  Alm, Ann Sophie ^a   Ingvarsson, Annika ^b   Wang, Xiangdong ^c,d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c ZHEJIANG UNIVERSITY   (China)

^d NONE   (Sweden)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Hyperinflation; Lung; Therapy

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; FORMOTEROL; SALBUTAMOL; SALMETEROL; STEROID; TIOTROPIUM BROMIDE;

AIRWAY PRESSURE; ASTHMA; BREATHING MUSCLE; CARDIOVASCULAR SYSTEM; CELL HYPERPLASIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; DISEASE SEVERITY; EMPHYSEMA; GOBLET CELL; HUMAN; HYPERINFLATION; INFLAMMATION; LUNG ALVEOLUS WALL; MEDICAL TECHNOLOGY; METAPLASIA; MUCUS SECRETION; PATHOGENESIS; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THORAX WALL;

EID: 33947147747     PISSN: 17471060     EISSN: 17471079     Source Type: Journal    
DOI: 10.1080/17471060600845190     Document Type: Review

References (79)

1. Colasanti RL, Morris MJ, Madgwick RG, Sutton L, Williams EM. Analysis of tidal breathing profiles in cystic fibrosis and COPD. Chest 2004;125:901-8.
2. Gibson G. Pulmonary hyperinflation a clinical overview. Eur Respir J 1996;9:2640-9.
3. Palecek F. Hyperinflation: control of functional residual lung capacity. Physiol Res 2001;50:221-30.
4. Pecchiari M, Pelucchi A, D'Angelo E, Foresi A, Milic-Emili J, D'Angelo E. Effect of heliox breathing on dynamic hyperinflation in COPD patients. Chest 2004;125:2075-82.
5. Rossi A, Ganassini A, Polese G, Grassi V. Pulmonary hyperinflation and ventilator-dependent patients. Eur Respir J 1997;10:1663-74.
6. Tantucci C, Duguet A, Similowski T, Zelter M, Derenne JP, Milic-Emili J. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Eur Respir J 1998;12:799-804.
7. Man WD, Mustfa N, Nikoletou D, Kaul S, Hart N, Rafferty GF, et al. Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD. Thorax 2004;59:471-6.
8. Laghi F, Segal J, Choe WK, Tobin MJ. Effect of imposed inflation time on respiratory frequency and hyperinflation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1365-70.
9. Bohadana A, Teculescu D, Martinet Y. Mechanisms of chronic airway obstruction in smokers. Respir Med 2004;98:139-51.
10. Shapiro SD. Proteinases in chronic obstructive pulmonary disease. Biochem Soc Trans 2001;30:98-102.
11. Senior RM, Anthonisen R. Chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 1998;157:S139-47.
12. Petty TL, Weinmann GG. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. National Heart, Lung, and Blood Institute Workshop Summary. JAMA 1997;277:246-53.
13. Turato G, Zuin R, Miniati M, Baraldo S, Rea F, Beghé B, et al. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. Am J Respir Crit Care Med 2002;166:105-10.
14. Norman P. COPD: new developments and therapeutic opportunities. Drug News Perspect 1998;11:431-7.
15. Rubin EM, Baier H. Unilateral pulmonary hyperinflation from mucus check-valve mechanism. Crit Care Med 1986;14:828-9.
16. Willemse BWM, Postma DS, Timens W, Ten Hacken NHT. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 2004;23:464-76.
17. Molfino NA. Genetics of COPD. Chest 2004;125:1929-40.
18. Barnes PJ. New concepts in chronic obstructive pulmonary disease. Annu Rev Med 2003;54:113-29.
19. Duranti R, Filippelli M, Bianchi R, Romangnoli I, Pellegrino R, Brusasco V, et al. Inspiratory capacity and decrease in lung hyperinflation with albuterol in COPD. Chest 2002;122:2009-14.
20. Di Marco F, Milic-Emili J, Boveri B, Carlucci P, Santus P, Casanova F, et al. Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD. Eur Respir J 2003;21:86-94.
21. Celli B, ZuWallack R, Wang S, Kesten S. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest 2003;124:1743-8.
22. Taube C, Lehnigk B, Paasch K, Kirsten DK, Jörres RA, Magnussen H. Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162:216-20.
23. Dykstra BJ, Scanlon PD, Kester MM, Beck KC, Enright PL. Lung volumes in 4,774 patients with obstructive lung disease. Chest 1999;115:68-74.
24. Meneely GR, Kaltreider NL. The volume of the lung determined by helium dilution. Description of the method and comparison with other procedures. J Clin Invest 1949;28:129-39.
25. Morris MG. The open circuit nitrogen washout technique for measuring the lung volume in infants: methodological aspects. Thorax 1999;54:790-5.
26. Hammer J, Numa A, Newth CJL. Total lung capacity by N2 washout from high and low lung volumes in ventilated infants and children. Am J Respir Crit Care Med 1998;158:526-31.
27. Gappa M, Fletcher ME, Dezateux CA, Stocks J. Comparison of nitrogen washout and plethysmographic measurements of lung volume in healthy infants. Am Rev Respir Dis 1993;148:1496-501.
28. Sivan Y, Hammer J, Newth CJ. Measurement of high lung volumes by nitrogen washout method. J Appl Physiol 1994;77:1562-4.
29. Dahlqvist M, Hedenstierna G. Lung volumes measured by helium dilution and by body plethysmography with mouth and oesophageal pressures: a comparative study in patients with lung disease. Clin Physiol 1985;5:179-87.
30. Johnson MM, Ely EW, Chiles C, Bowton DL, Friemanas RI, Choplin RH, et al. Radiographic assessment of hyperinflation: correlation with objective chest radiographic measurements and mechanical ventilator parameters. Chest 1998;113:1698-704.
31. Dellaca RL, Santus P, Aliverti A, Stevenson N, Centanni S, Macklem PT, et al. Detection of expiratory flow limitation in COPD using the forced oscillation technique. Eur Respir J 2004;23:232-40.
32. Zerah F, Lorino A-M, Lorino H, Harf A, Macquin-Mavier I. Forced oscillation technique vs spirometry to assess bronchodilatation in patients with asthma and COPD. Chest 1995;108:41-7.
33. Oostveen E, MacLeod D, Lorino H, Farre R, Hantos Z, Desager K, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J 2003;22:1026-41.
34. Ley S, Zaporozhan J, Morbach A, Eberle B, Gast KK, Heussel CP, et al. Functional evaluation of emphysema using diffusion-weighted 3Helium-magnetic resonance imaging, high-resolution computed tomography, and lung function tests. Invest Radiol 2004;39:427-34.
35. Hogg JC, Wright JL, Wiggs BR, Coxson HO, Opazo Saez A, Pare PD. Lung structure and function in cigarette smokers. Thorax 1994;49:473-8.
36. Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000;162:1102-8.
37. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003;22:672-88.
38. Cerveri I, Dore R, Corsico A, Zoia MC, Pellegrino R, Brusasco V, et al. Assessment of emphysema in COPD: a functional and radiologic study. Chest 2004;125:1714-8.
39. Dueck R. Assessment and monitoring of flow limitation and other parameters from flow/volume loops. J Clin Monit Comput 2000;16:425-32.
40. Vestbro J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996;153:1530-5.
41. Keam SJ, Keating GM. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD. Treat Respir Med 2004;3:247-68.
42. Teculescu DB, Pham QT, Hannhart B. Tests of small airway dysfunction: their correlation with the "conventional" lung function tests. Eur J Respir Dis 1986;69:175-87.
43. Fletcher CM, Peto R, Tinker CM, Spizer FE. The natural history of chronic bronchitis and emphysema. Oxford, UK: Oxford University Press; 1976.
44. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-53.
45. Jansson AH, Eriksson C, Wang XD. Effects of budesonide treatments on liopolysaccharide-induced chronic lung changes in rats. Vasc Pharmacol 2005;43:101-11.
46. Jansson AH, Eriksson C, Wang XD. Lung inflammatory responses and hyperinflation induced by an intratracheal exposure to lipopolysaccharide in rats. Lung 2004;182:163-71.
47. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000;343:269-80.
48. Wright J, Lawson LM, Pare PD, Wiggs BJ, Kennedy S, Hogg JC. Morphology of peripheral airways in current smokers and ex-smokers. Am Rev Respir Dis 1983;127:474-7.
49. Pellegrino R, Brusasco V. On the causes of lung hyperinflation during bronchoconstriction. Eur Respir J 1997;10:468-75.
50. Cassart M, Pettuaux N, Gevenois PA, Paiva M, Estenne M. Effect of chronic hyperinflation on diaphragm length and surface area. Am J Respir Crit Care Med 1997;156:504-8.
51. Brusasco V, Fitting J. Lung hyperinflation in airway obstruction. Eur Respir J 1996;9:2440.
52. De Troyer A. Effect of hyperinflation on the diaphragm. Eur Respir J 1997;10:708-13.
53. Decramer M. Hyperinflation and respiratory muscle interaction. Eur Respir J 1997;10:934-41.
54. Sietsema K. Cardiovascular limitations in chronic pulmonary disease. Med Sci Sports Exerc 2001;33:S656-61.
55. Stark-Leyva KN, Beck KC, Johnson BD. Influence of expiratory loading and hyperinflation on cardiac output during exercise. J Appl Physiol 2004;96:1920-7.
56. Newton MF, O'Donnell DE, Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest 2002;121:1042-50.
57. O'Donnell DE, Forkert L, Webb KA. Evaluation of bronchodilator responses in patients with "irreversible" emphysema. Eur Respir J 2001;18:914-20.
58. Ramirez-Venegas A, Ward J, Lentine T, Mahler DA. Salmeterol reduces dyspnea and improves lung function in patients with COPD. Chest 1997;112:336-40.
59. O'Donnell DE, Flüge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004;23:832-40.
60. Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Desten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 2005;127:809-17.
61. Somfay A, Porszasz J, Lee SM, Casaburi R. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. Eur Respir J 2001;18:77-84.
62. Palange P, Valli G, Onorati P, Antonucci R, Paoletti P, Rosato A, et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol 2004;97:1637-42.
63. Greenough A, Pool J, Gleeson JG, Price JF. Effect of budesonide on pulmonary hyperinflation in young asthmatic children. Thorax 1988;43:937-8.
64. John M, Bosse S, Oltmanns U, Schumacher A, Witt C. Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease. Respir Med 2005;99:1418-24.
65. Donohue JF. Therapeutic responses in asthma and COPD: bronchodilators. Chest 2004;126:125S-37.
66. Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003;361:449-56.
67. Russi E, Stammberger U, Weder W. Lung volume reduction surgery for emphysema. Eur Respir J 1997;10:208-18.
68. Dueck R, Cooper S, Kapelanski D, Colt H, Clausen J. A pilot study of expiratory flow limitation and lung volume reduction. Surg Chest 1999;116:1762-71.
69. Yusen RD, Lefrak SS, Gierada DS, Davis GE, Meyers BF, Patterson GA, et al. A prospective evaluation of lung volume reduction surgery in 200 consecutive patients. Chest 2003;123:1026-37.
70. Bloch KE, Weder W, Boehler A, Zalunardo MP, Russi EW. Successful lung volume reduction surgery in a child with severe airflow obstruction and hyperinflation due to constrictive bronchiolitis. Chest 2002;122:747-50.
71. Goldstein RS, Todd TRJ, Guyatt G, Keshavjee S, Dolmage TE, van Rooy S, et al. Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease. Thorax 2003;58:405-10.
72. Murciano D, Ferretti A, Boczkowski J, Sleiman C, Fournier M, Milic-Emili J. Flow limitation and dynamic hyperinflation during exercise in COPD patients after single lung transplantation. Chest 2000;118:1248-54.
73. Angles R, Tenorio L, Roman A, Soler J, Rochera M, de Latorre FJ. Lung transplantation for emphysema. Lung hyperinflation: incidence and outcome. Transpl Int 2005;17:810-4.
74. Sciurba FC. Physiologic similarities and differences between COPD and asthma. Chest 2004;126:117S-24.
75. Gorini M, Iandelli I, Misuri G, Beroli F, Filippelli M, Mancini M, et al. Chest wall hyperinflation during acute bronchoconstriction in asthma. Am J Respir Crit Care Med 1999;160:808-16.
76. Pellegrino R, Brusasco V. Lung hyperinflation and flow limitation in chronic airway obstruction. Eur Respir J 1997;10:543-9.
77. Cassino C, Berger KI, Goldring RM, Norman RG, Kammerman S, Ciotoli C, et al. Duration of asthma and physiologic outcomes in elderly nonsmokers. Am J Respir Crit Care Med 2000;162:1423-8.
78. Elias J. The relationship between asthma and COPD: lessons from transgenic mice. Chest 2004;126:111S-6.
79. Barnes PJ. Mechanisms in COPD: differences from asthma. Chest 2000;117:10S-14.